Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of QIVc in Subjects ≥2 to <18 Years of Age
Clinical trial NCT03165617 · COMPLETED
Trial details
- NCT number
- NCT03165617
- Sponsor
- Seqirus
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-25
- Primary completion
- 2019-09-30
- Enrollment
- 4514
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.